medigraphic.com
Instituto Nacional de Salud Pública

2022, Number 4

<< Back Next >>

salud publica mex 2022; 64 (4)

Validity and reliability of the polydiagnostic inventory for psychotic disorders OPCRIT 4.0 adapted to Spanish

Martínez-Leal R, Soriano M, Salvador-Carulla L, Folch-Mas A

Language: Spanish
References: 39
Page: 406-414
PDF size: 324.52 Kb.


ABSTRACT

Objective. This study proposes the Spanish adaptation and validation of the operational criteria OPCRIT checklist for psychotic disorders 4.0. This instrument provides a diagnosis based on several diagnostic systems. Materials and methods. The original inventory was translated into Spanish and then back-translated into the original English language. We tested the criterion-validity, the concurrent validity and the inter-rater reliability from a sample of 106 clinical records of adult patients from a local community mental health center. Results. The data obtained demonstrated the validity and reliability of the OPCRIT 4.0 adaptation in the evaluation of the sample of medical records. Conclusions. The OPCRIT 4.0 Spanish adaptation and validation provides a fast, reliable, and useful system allows the diagnosis of psychotic disorders through different classification systems.


REFERENCES

  1. Dennison CA, Legge SE, Pardiñas AF, Walters JTR. Genome-wideassociation studies in schizophrenia: Recent advances, challenges andfuture perspective. Schizophrenia Research. 2020;217:4-12. https://doi.org/10.1016/j.schres.2019.10.048

  2. Forsyth JK, Asarnow RF. Genetics of Childhood-onset Schizophrenia2019 Update. Child Adolesc Psychiatr Clin N Am. 2020;29:157-70. https://doi.org/10.1016/j.chc.2019.08.007

  3. Seidman LJ, Mirsky AF. Evolving notions of schizophrenia as a developmentalneurocognitive disorder. J Int Neuropsychol Soc. 2017;23:881-92.https://doi.org/10.1017/S1355617717001114

  4. Al-Diwani AAJ, Pollak TA, Irani SR, Lennox BR. Psychosis: an autoimmunedisease? Immunology. 2017;152:388-401. https://doi.org/10.1111/imm.12795

  5. Kroken RA, Sommer IE, Steen VM, Dieset I, Johnsen E. Constructing theimmune signature of schizophrenia for clinical use and research; an integrativereview translating descriptives into diagnostics. Front Psychiatry.2019;31:753. https://doi.org/10.3389/fpsyt.2018.00753

  6. Van Kesteren CFMG, Gremmels H, De Witte LD, Hol EM, Van Gool AR,Falkai PG, et al. Immune involvement in the pathogenesis of schizophrenia:A meta-analysis on postmortem brain studies. Transl Psychiatry.2017;7:e1075. https://doi.org/10.1038/tp.2017.4

  7. Radua J, Ramella-Cravaro V, Ioannidis JPA, Reichenberg A, PhiphopthatsaneeN, Amir T, et al. What causes psychosis? An umbrella review of riskand protective factors. World Psychiatry. 2018;17:49-66. https://doi.org/10.1002/wps.20490

  8. Dean B, Copolov D, Scarr E. Understanding the pathophysiology ofschizophrenia: Contributions from the Melbourne Psychiatric BrainBank. Schizophrenia Research. 2016;177:108-14. https://doi.org/10.1016/j.schres.2016.04.037

  9. Foley C, Corvin A, Nakagome S. Genetics of Schizophrenia: Ready toTranslate? Curr Psychiatry Rep. 2017;19:61. https://doi.org/10.1007/s11920-017-0807-5

  10. Misiak B, Stramecki F, Gawęda Ł, Prochwicz K, Sąsiadek MM, MoustafaAA, Frydecka D. Interactions between variation in candidate genesand environmental factors in the etiology of schizophrenia and bipolardisorder: a systematic review. Molecular Neurobiology. 2018;55:5075-100.https://doi.org/10.1007/s12035-017-0708-y

  11. Zwicker A, Denovan-Wright EM, Uher R. Gene-environment interplayin the etiology of psychosis. Psychological Medicine. 2018;48:1925-36.https://doi.org/10.1017/S003329171700383X

  12. Migdalska-Richards A, Mill J. Epigenetic studies of schizophrenia:current status and future directions. Curr Opin Behav Sci. 2019;25:102-10.https://doi.org/10.1016/j.cobeha.2018.12.003

  13. Jablensky A. The diagnostic concept of schizophrenia: its history, evolution,and future prospects. Dialogues Clin Neurosci. 2010;12:271-87.

  14. Möller H. Is schizophrenia still one entity with similar symptomaticpatterns, neurobiological characteristics, and treatment perspectives? EurArch Psychiatry Clin Neurosci. 2018;268:525-7. https://doi.org/10.1007/s00406-018-0926-y

  15. Merritt J, Tanguturi Y, Fuchs C, Cundiff A. W. medical etiologies ofsecondary psychosis in children and adolescents. Child Adolesc PsychiatrClin N Am. 2020;29:29-42. https://doi.org/10.1016/j.chc.2019.08.005

  16. Kircher T, Wöhr M, Nenadic I, Schwarting R, Schratt G, Alferink J, et al.Neurobiology of the major psychoses: a translational perspective on brainstructure and function—the FOR2107 consortium. Eur Arch Psychiatry ClinNeurosci. 2019;269:949-62. https://doi.org/10.1007/s00406-018-0943-x

  17. Tandon R, Gaebel W, Barch DM, Bustillo J, Gur RE, Heckers S,et al. Definition and description of schizophrenia in the DSM-5.Schizophrenia Research. 2013;150(1):3-10. https://doi.org/10.1016/j.schres.2013.05.028

  18. Maj M. Critique of the DSM-IV operational diagnostic criteria forschizophrenia. Br J Psychiatry. 1998;172:458-60. https://doi.org/10.1192/BJP.172.6.458

  19. Peralta V, Cuesta MJ. Clinical models of schizophrenia: a criticalapproach to competing conceptions. Psychopathology. 2000;33:252-8.https://doi.org/10.1159/000029154

  20. Kendler KS. Phenomenology of schizophrenia and the representativenessof modern diagnostic criteria. JAMA Psychiatry. 2016;73:1082-92.https://doi.org/10.1001/jamapsychiatry.2016.1976

  21. Peralta V, Goldberg X, Ribeiro M, Sanchez-Torres AM, Fañanás L,Cuesta MJ. Familiality of psychotic disorders: A polynosologic study inmultiplex families. Schizophr Bull. 2016;42:975-83. https://doi.org/10.1093/schbul/sbv192

  22. McGuffin P, Farmer A, Harvey I. A polydiagnostic application of operationalcriteria in studies of psychotic illness. Development and reliability ofthe OPCRIT system. Arch Gen Psychiatr. 1991;48:764-70.

  23. Cardno AG, Jones LA, Murphy KC, Asherson P, Scott LC, WilliamsJ, et al. Factor analysis of schizophrenic symptoms using the OPCRITchecklist. Schizophrenia Research. 1996;22:233-9. https://doi.org/S0920996496000606

  24. Brittain PJ, Stahl D, Rucker J, Kawadler J, Schumann G. A review of thereliability and validity of OPCRIT in relation to its use for the routineclinical assessment of mental health patients. Int J Methods Psychiatr Res.2013;22:110-37. https://doi.org/10.1002/mpr.1382

  25. Farmer AE, Jones I, Williams J, McGuffin P. Defining schizophrenia:Operational criteria. J Ment Health. 1993;2:209-22. https://doi.org/10.3109/09638239309003767

  26. Oliveira L, Pereira A, Nogueira V, Soares MJ, Valente J, Dourado A, etal. Symptom dimensions of psychosis – opcrit factorial analysis of a largesample of portuguese psychotic patients. Eur Psychiatry. 2015;30:349.https://doi.org/10.1016/S0924-9338(15)30274-1

  27. Quattrone D, Di Forti M, Gayer-Anderson C, Ferraro L, JongsmaHE, Tripoli G, et al. Transdiagnostic dimensions of psychopathology atfirst episode psychosis: Findings from the multinational EU-GEI study.Psychological Medicine. 2019;49:1378-91. https://doi.org/10.1017/S0033291718002131

  28. Craddock M, Asherson P, Owen MJ, Williams J, McGuffin P, Farmer AE.Concurrent validity of the OPCRIT diagnostic system. Comparison ofOPCRIT diagnoses with consensus best-estimate lifetime diagnoses. Br JPsychiatry. 1996;169:58-63.

  29. Wiesinger GF, Nuhr M, Quittan M, Ebenbichler G, Wölfl G, Fialka-Moser V. Cross-cultural adaptation of the Roland-Morris questionnaire forGerman-speaking patients with low back pain. Spine. 1999;24:1099-103.

  30. Hutchinson A, Bentzen N, König-Zahn C. Cross-cultural health outcomeassessment: a user’s guide. Groningen: ERGHO, 1997.

  31. Landis JR, Koch GG. The measurement of observer agreement forcategorical data. Biometrics. 1977;33:159-174.

  32. Azevedo MH, Soares MJ, Coelho I, Dourado A, Valente J, Macedo A, etal. Using consensus OPCRIT diagnoses. An efficient procedure for best-estimatelifetime diagnoses. The British Journal of Psychiatry. 1999;175:154-7.https://doi.org/10.1192/bjp.175.2.154

  33. Martínez-Leal R, Soriano-Peña MF, Moreno-Küstner B. Falta de insighten la esquizofrenia. Cuadernos de Psiquiatría Comunitaria. 2004;4:146-58.

  34. Wing JK, Babor T, Brugha T, Burke J, Cooper JE, Giel R, et al. Schedulesfor Clinical Assessment in Neuropsychiatry. Arch Gen Psychiatry.1990;47:589-93. https://doi.org/10.1001/archpsyc.1990.01810180089012

  35. Leckman JF, Sholomskas D, Thompson WD, Belanger A, Weissman MM.Best estimate of lifetime psychiatric diagnosis: a methodological study.Arch Gen Psychiatry. 1982;39:879-83.

  36. Serretti A, Lattuada E, Cusin C, Smeraldi E. Factor analysis of delusionaldisorder symptomatology. Compr Psychiatry. 1999;40:143-7. https://doi.org/10.1016/S0010-440X(99)90118-9

  37. Muñoz-Negro JE, Ibáñez-Casas I, de Portugal E, Lozano-Gutiérrez V,Martínez-Leal R, Cervilla JA. A Psychopathological Comparison betweenDelusional Disorder and Schizophrenia. Can J Psychiatry. 2018;63:12-19. https://doi.org/10.1177/0706743717706347

  38. McHugh ML. Interrater reliability: the kappa statistic. Biochem Med.2012;22:276-82.

  39. Bujang MA, Baharum N. Guidelines of the minimum sample size requirementsfor Cohen’s Kappa. Epidemiol Biostat Public Health. 2017;14:1-10. https://doi.org/10.2427/12267




2020     |     www.medigraphic.com